Here are five points:
1. NuVasive will pay $13.5 million, plus fees and accrued interest.
2. The company said it understands the government’s responsibility to ensure the appropriateness of industry practices.
3. NuVasive cooperated with the government and plans to sustain a compliant relationship.
4. This settlement allows NuVasive to avoid spending time and money on a litigation process, but does not imply an admission of liability by the company. NuVasive admits no wrongdoing.
5. The settlement did not require NuVasive to enter into a corporate integrity agreement by the OIG.
More articles on devices:
Is Stryker next for a big transaction? 7 key notes
Amendia acquires Custom Spine — 5 key notes
Exactech Q2 revenue down 4%: 10 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
